![Janet Hammond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Hammond
Corporate Officer/Principal at
ATEA PHARMACEUTICALS, INC.
Net worth: 596 196 $ as of 2026-05-30
Profile
Janet Hammond currently works at Enterprise Therapeutics Ltd., as Director from 2024, Atea Pharmaceuticals, Inc., as Chief Development Officer from 2020, and Roche Ltd., as Vice President-Translational Medicine from 2011.
Dr. Hammond also formerly worked at Bristol Myers Squibb Co., as Group Director-Virology Clinical Research, Bausch Health Americas, Inc., as Chief Medical Officer, SVP & Head-Medical Affairs, F.
Hoffmann-La Roche Ltd., as SVP & Head-China Infectious Disease from 2011 to 2016, Valeant Pharmaceutical, as Chief Medical Officer, SVP & Head-Medical Affairs, AbbVie, Inc., as VP, Head-General Medicine & Infectious Disease from 2016 to 2020, GSK Plc, as Head-Clinical Discovery, and Glaxo Wellcome, Inc., as Senior Clinical Research Physician.
Dr. Hammond received her doctorate degree from the University of Cape Town and graduate degree from Johns Hopkins Bloomberg School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 127,665 ( 0.16% ) | 596 196 $ | 2026-05-30 |
Janet Hammond active positions
| Companies | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-07-31 |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 2011-03-28 |
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Director/Board Member | 2024-04-30 |
Former positions of Janet Hammond
| Companies | Position | End |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 2020-07-31 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2016-10-31 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Chief Tech/Sci/R&D Officer | 2011-09-11 |
Valeant Pharmaceutical | Chief Tech/Sci/R&D Officer | - |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Training of Janet Hammond
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Johns Hopkins Bloomberg School of Public Health
 Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Health Technology |
Valeant Pharmaceutical |
- Stock Market
- Insiders
- Janet Hammond
